Drug Type Small molecule drug |
Synonyms Bosporon, Chlortenoxicam, Lornoxicam (JAN/USAN/INN) + [19] |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date DK (01 Jan 1997), |
Regulation- |
Molecular FormulaC13H10ClN3O4S2 |
InChIKeyWLHQHAUOOXYABV-UHFFFAOYSA-N |
CAS Registry70374-39-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01866 | Lornoxicam |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Rheumatic Diseases | JP | 20 Jun 2001 | |
Bursitis | JP | 02 Feb 2001 | |
Cervicobrachial syndrome | DK | - | 01 Jan 1997 |
Low Back Pain | DK | - | 01 Jan 1997 |
Neuralgia | DK | - | 01 Jan 1997 |
Osteoarthritis | DK | - | 01 Jan 1997 |
Pain, Postoperative | DK | - | 01 Jan 1997 |
Periarthritis | DK | - | 01 Jan 1997 |
Rheumatoid Arthritis | DK | - | 01 Jan 1997 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Headache | Phase 2 | US | 01 Dec 2005 | |
Migraine Disorders | Phase 2 | US | 01 Dec 2005 |
Phase 2 | 219 | (Lornoxicam) | aswfrzyjej(kommootkfi) = ooykymhqzh ynijjyqmdl (bhmjrtghmc, uozznqhjat - pficomoagp) View more | - | 29 Nov 2012 | ||
Placebo (Placebo) | aswfrzyjej(kommootkfi) = shmwibiewk ynijjyqmdl (bhmjrtghmc, irauhqbymx - jepzozzcmp) View more |